NPTX2

NPTX2 is a secreted neuronal pentraxin and immediate-early gene that functions as a trans-synaptic organizer of excitatory drive onto fast-spiking parvalbumin interneurons, thereby maintaining excitatory–inhibitory balance, network rhythmicity, and memory precision. Expressed presynaptically by excitatory pyramidal neurons, NPTX2 clusters GluA4-containing AMPA receptors at postsynaptic sites on parvalbumin interneurons through its pentraxin domain, and its activity-dependent exocytosis and synaptic shedding are required for adaptive circuit responses to behavioral stress (PMID:28440221, PMID:34818031, PMID:40057261, PMID:41000823). NPTX2 also directly binds complement C1q to inhibit complement-mediated microglial synapse elimination, and its loss leads to excessive C1q-dependent excitatory synapse engulfment (PMID:36989373). TDP-43 regulates NPTX2 protein levels by binding the 3′ UTR of NPTX2 mRNA; loss of nuclear TDP-43 causes neurotoxic NPTX2 misaccumulation, linking NPTX2 dysregulation to ALS/FTLD neurodegeneration (PMID:38355792).

1. 1995 High

   Identification of NPTX2 as a brain-expressed pentraxin family member established the gene's molecular identity and tissue distribution, opening the question of its neuronal function.

   Evidence cDNA cloning, Northern blot, genomic sequencing, and chromosomal mapping in human tissues

   PMID:8530029

   Open questions at the time

   • No functional role determined
   • No synaptic localization or binding partners identified
   • Pentraxin domain function unknown
2. 2017 High

   Demonstration that NPTX2 is expressed presynaptically by pyramidal neurons and controls postsynaptic GluA4-AMPA receptor levels on parvalbumin interneurons resolved its primary synaptic function and linked its loss to network hyperexcitability and disrupted rhythmicity in an AD amyloidosis model.

   Evidence Nptx2 knockout mouse crossed with amyloid model, electrophysiology, immunohistochemistry, human postmortem cortex validation

   PMID:28440221

   Open questions at the time

   • Mechanism of NPTX2-mediated GluA4 clustering not defined at structural level
   • Whether NPTX2 loss is cause or consequence of AD network dysfunction unclear
   • Contributions of other neuronal pentraxins (NPTX1, NPTXR) not separated
3. 2018 High

   Region-specific hippocampal knockout and overexpression revealed that NPTX2 regulates anxiety behavior and stress-related glucocorticoid signaling, extending its role beyond synapse organization to behavioral homeostasis.

   Evidence Hippocampus-specific Nptx2 KO and OE in mice, behavioral anxiety tests, glucocorticoid target gene expression, adult neurogenesis assessment

   PMID:29844474

   Open questions at the time

   • How NPTX2's synaptic function translates to glucocorticoid receptor gene regulation is unknown
   • Amygdala-independent mechanism not fully characterized
4. 2019 High

   Identification that retrieval-induced NPTX2 recruits GluA1-AMPA receptors via its pentraxin domain to facilitate extinction of cocaine-associated memory demonstrated domain-specific receptor recruitment in a memory updating context.

   Evidence Ribosomal tagging, electrophysiology, dominant-negative GluA1 overexpression, hippocampal NPTX2 manipulation in mice

   PMID:31836174

   Open questions at the time

   • Whether GluA1 versus GluA4 recruitment reflects circuit-specific differences or stimulus-specific differences unresolved
   • Structural basis of pentraxin domain–AMPAR interaction unknown
5. 2021 High

   Demonstration that NPTX2 requires activity-dependent exocytosis and dynamic synaptic shedding — abolished by specific plasticity-disrupting mutations — established the regulated trafficking mechanism underlying its trans-synaptic signaling.

   Evidence NPTX2 trafficking assays, site-directed mutagenesis, Nptx2 loss-of-function mouse, behavioral stress paradigms, electrophysiology

   PMID:34818031

   Open questions at the time

   • Identity of the protease(s) mediating NPTX2 ectodomain shedding not determined
   • Exact activity-dependent signaling cascade triggering exocytosis not delineated
6. 2023 High

   Discovery that secreted NPTX2 directly binds complement C1q and restrains microglial synapse engulfment revealed a second, complement-inhibitory mechanism by which NPTX2 protects excitatory synapses, with AAV rescue confirming causality.

   Evidence Co-IP of NPTX2–C1q complex in CSF, Nptx2 KO mouse, AAV overexpression rescue, synapse engulfment assays, aged TauP301S mice

   PMID:36989373

   Open questions at the time

   • Binding interface between NPTX2 and C1q not structurally resolved
   • Whether NPTX2–C1q interaction is relevant at inhibitory synapses untested
   • Relative contributions of AMPAR-clustering versus complement-inhibition to synapse protection not quantified
7. 2023 Medium

   NPTX2 knockout mice show sleep fragmentation, disrupted circadian onset, altered EEG spectral power, and decreased sleep spindles independent of orexin, establishing a direct role for NPTX2 in sleep/circadian regulation.

   Evidence Nptx2 KO mouse, sleep EEG/polysomnography, circadian activity monitoring (preprint)

   PMID:37808783

   Open questions at the time

   • Preprint not yet peer-reviewed
   • Circuit mechanism linking NPTX2 loss to sleep architecture disruption not identified
   • Interaction with known circadian clock genes untested
8. 2024 High

   Identification of TDP-43 as a direct regulator of NPTX2 mRNA via 3′ UTR binding connected NPTX2 misregulation to ALS/FTLD neurodegeneration, showing that TDP-43 loss causes neurotoxic NPTX2 misaccumulation and that correcting NPTX2 levels partially rescues TDP-43-induced neurodegeneration.

   Evidence iPSC-derived neural networks, single-cell transcriptomics, TDP-43 manipulation, NPTX2 overexpression/correction, human ALS/FTLD tissue validation

   PMID:38355792

   Open questions at the time

   • Mechanism of NPTX2-induced neurotoxicity upon misaccumulation not defined
   • Whether TDP-43 regulation of NPTX2 is direct or involves intermediary RNA-binding events needs further dissection
9. 2025 Medium

   Engram-specific manipulation showed NPTX2's AMPAR-binding domain facilitates perisomatic inhibition of dentate gyrus ensemble neurons by PV interneurons, preventing fear memory overgeneralization in aged mice and establishing a memory-precision function.

   Evidence Engram-specific NPTX2 depletion/overexpression, chemogenetic PV interneuron activation, contextual fear memory paradigms (preprint)

   PMID:41000823

   Open questions at the time

   • Preprint not yet peer-reviewed
   • Whether the memory precision role extends beyond fear conditioning untested
   • Contribution of NPTX2's complement-inhibitory function to engram stability not assessed

• Major open questions include the structural basis of NPTX2's pentraxin domain interactions with AMPAR subunits and C1q, the protease(s) responsible for synaptic shedding, the mechanism by which NPTX2 misaccumulation is neurotoxic, and how its AMPAR-clustering and complement-inhibitory functions are coordinated at the synapse.
• No crystal or cryo-EM structure of NPTX2 or its complexes
• Shedding protease identity unknown
• Relative in vivo contributions of dual mechanisms not quantified